1. Home
  2. QNCX vs SCWO Comparison

QNCX vs SCWO Comparison

Compare QNCX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • SCWO
  • Stock Information
  • Founded
  • QNCX 2012
  • SCWO 2021
  • Country
  • QNCX United States
  • SCWO United States
  • Employees
  • QNCX N/A
  • SCWO N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • SCWO Environmental Services
  • Sector
  • QNCX Health Care
  • SCWO Utilities
  • Exchange
  • QNCX Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • QNCX 92.3M
  • SCWO 81.5M
  • IPO Year
  • QNCX 2019
  • SCWO N/A
  • Fundamental
  • Price
  • QNCX $1.60
  • SCWO $0.48
  • Analyst Decision
  • QNCX Strong Buy
  • SCWO
  • Analyst Count
  • QNCX 4
  • SCWO 0
  • Target Price
  • QNCX $9.50
  • SCWO N/A
  • AVG Volume (30 Days)
  • QNCX 147.1K
  • SCWO 398.7K
  • Earning Date
  • QNCX 11-13-2024
  • SCWO 11-13-2024
  • Dividend Yield
  • QNCX N/A
  • SCWO N/A
  • EPS Growth
  • QNCX N/A
  • SCWO N/A
  • EPS
  • QNCX N/A
  • SCWO N/A
  • Revenue
  • QNCX N/A
  • SCWO $313,930.00
  • Revenue This Year
  • QNCX N/A
  • SCWO N/A
  • Revenue Next Year
  • QNCX N/A
  • SCWO $5,180.00
  • P/E Ratio
  • QNCX N/A
  • SCWO N/A
  • Revenue Growth
  • QNCX N/A
  • SCWO N/A
  • 52 Week Low
  • QNCX $0.51
  • SCWO $0.48
  • 52 Week High
  • QNCX $2.45
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 42.75
  • SCWO 17.64
  • Support Level
  • QNCX $1.40
  • SCWO $0.54
  • Resistance Level
  • QNCX $1.79
  • SCWO $0.61
  • Average True Range (ATR)
  • QNCX 0.15
  • SCWO 0.06
  • MACD
  • QNCX -0.02
  • SCWO 0.00
  • Stochastic Oscillator
  • QNCX 32.79
  • SCWO 1.27

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: